Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $11.64 USD
Change Today -0.05 / -0.43%
Volume 7.9K
PMD On Other Exchanges
Symbol
Exchange
NASDAQ CM
Berlin
As of 8:10 PM 08/4/15 All times are local (Market data is delayed by at least 15 minutes).

psychemedics corp (PMD) Snapshot

Open
$12.07
Previous Close
$11.69
Day High
$12.07
Day Low
$11.60
52 Week High
04/27/15 - $17.83
52 Week Low
07/21/15 - $9.82
Market Cap
63.1M
Average Volume 10 Days
18.0K
EPS TTM
$0.44
Shares Outstanding
5.4M
EX-Date
08/5/15
P/E TM
26.7x
Dividend
$0.60
Dividend Yield
5.15%
Current Stock Chart for PSYCHEMEDICS CORP (PMD)

Related News

No related news articles were found.

psychemedics corp (PMD) Related Businessweek News

No Related Businessweek News Found

psychemedics corp (PMD) Details

Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States and internationally. The company’s testing methods utilize a patented technology that focuses on digesting hair and releasing drugs trapped in the hair without destroying the drugs. The company’s tests provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data, which can show a pattern of individual drug use over a longer period of time. It offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, PCP, amphetamines, and opiates, including heroin, hydrocodone, hydromorphone, oxycodone, and codeine. Psychemedics Corporation offers its services to employers for applicant and employee testing; physicians, treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children’s drug use; and Fortune 500 companies and small to mid-size corporations. The company was founded in 1985 and is headquartered in Acton, Massachusetts.

156 Employees
Last Reported Date: 02/27/15
Founded in 1985

psychemedics corp (PMD) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $536.9K
Vice President of Laboratory Operations
Total Annual Compensation: $310.3K
Corporate Vice President of Sales & Marketing
Total Annual Compensation: $241.8K
Compensation as of Fiscal Year 2014.

psychemedics corp (PMD) Key Developments

Psychemedics Corporation Adopts the Amended and Restated Bylaws

On July 28, 2015, the Board of Directors of Psychemedics Corporation adopted the Psychemedics Corporation Amended and Restated Bylaws to implement additional informational and other procedures for stockholder nominations and proposals in order to enable the Board to better analyze, evaluate and make recommendations to the company's stockholders with respect to such nominations and proposals and to increase the information available to stockholders if nominations and proposals are submitted for stockholder approval, and to clarify certain items. The Amended and Restated Bylaws include certain provisions that are consistent with current custom and practice, and differ from and clarify certain items in the company's previous bylaws.

Psychemedics Corp. Announces Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

Psychemedics Corp. announced unaudited earnings results for the second quarter and six months ended June 30, 2015. For the quarter, revenues were $7,001,409 against $7,694,137 a year ago. Operating income was $356,046 against $1,319,708 a year ago. Net income before provision for income taxes was $325,169 against $1,322,943 a year ago. Net income and comprehensive income was $252,329 against $856,919 a year ago. Basic and diluted net income per share was $0.05 against $0.16 a year ago. For the six months, revenues were $13,757,150 against $14,738,958 a year ago. Operating income was $806,561 against $2,487,760 a year ago. Net income before provision for income taxes was $742,357 against $2,492,544 a year ago. Net income and comprehensive income was $529,851 against $1,613,078 a year ago. Basic and diluted net income per share was $0.10 against $0.30 a year ago.

Psychemedics Corporation Announces a Quarterly Dividend, Payable on August 18, 2015

Psychemedics Corporation announced a quarterly dividend of $0.15 per share payable to shareholders of record as of August 7, 2015 to be paid on August 18, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PMD:US $11.64 USD -0.05

PMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alliance HealthCare Services Inc $14.98 USD -0.40
Enzo Biochem Inc $3.01 USD +0.03
Genomic Health Inc $26.27 USD -0.76
NeoGenomics Inc $6.02 USD -0.05
Response Genetics Inc $0.12 USD 0.00
View Industry Companies
 

Industry Analysis

PMD

Industry Average

Valuation PMD Industry Range
Price/Earnings 29.7x
Price/Sales 2.2x
Price/Book 5.3x
Price/Cash Flow 29.9x
TEV/Sales 2.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PSYCHEMEDICS CORP, please visit www.psychemedics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.